Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.
NIHR Applied Research Collaboration, East Midlands, UK.
Health Technol Assess. 2021 Dec;25(77):1-190. doi: 10.3310/hta25770.
Type 2 diabetes is a leading cause of mortality globally and accounts for significant health resource expenditure. Increased physical activity can reduce the risk of diabetes. However, the longer-term clinical effectiveness and cost-effectiveness of physical activity interventions in those at high risk of type 2 diabetes is unknown.
To investigate whether or not Walking Away from Diabetes (Walking Away) - a low-resource, 3-hour group-based behavioural intervention designed to promote physical activity through pedometer use in those with prediabetes - leads to sustained increases in physical activity when delivered with and without an integrated mobile health intervention compared with control.
Three-arm, parallel-group, pragmatic, superiority randomised controlled trial with follow-up conducted at 12 and 48 months.
Primary care and the community.
Adults whose primary care record included a prediabetic blood glucose measurement recorded within the past 5 years [HbA ≥ 42 mmol/mol (6.0%), < 48 mmol/mol (6.5%) mmol/mol; fasting glucose ≥ 5.5 mmol/l, < 7.0 mmol/l; or 2-hour post-challenge glucose ≥ 7.8 mmol/l, < 11.1 mmol/l] were recruited between December 2013 and February 2015. Data collection was completed in July 2019.
Participants were randomised (1 : 1 : 1) using a web-based tool to (1) control (information leaflet), (2) Walking Away with annual group-based support or (3) Walking Away Plus (comprising Walking Away, annual group-based support and a mobile health intervention that provided automated, individually tailored text messages to prompt pedometer use and goal-setting and provide feedback, in addition to biannual telephone calls). Participants and data collectors were not blinded; however, the staff who processed the accelerometer data were blinded to allocation.
The primary outcome was accelerometer-measured ambulatory activity (steps per day) at 48 months. Other objective and self-reported measures of physical activity were also assessed.
A total of 1366 individuals were randomised (median age 61 years, median body mass index 28.4 kg/m, median ambulatory activity 6638 steps per day, women 49%, black and minority ethnicity 28%). Accelerometer data were available for 1017 (74%) and 993 (73%) individuals at 12 and 48 months, respectively. The primary outcome assessment at 48 months found no differences in ambulatory activity compared with control in either group (Walking Away Plus: 121 steps per day, 97.5% confidence interval -290 to 532 steps per day; Walking Away: 91 steps per day, 97.5% confidence interval -282 to 463). This was consistent across ethnic groups. At the intermediate 12-month assessment, the Walking Away Plus group had increased their ambulatory activity by 547 (97.5% confidence interval 211 to 882) steps per day compared with control and were 1.61 (97.5% confidence interval 1.05 to 2.45) times more likely to achieve 150 minutes per week of objectively assessed unbouted moderate to vigorous physical activity. In the Walking Away group, there were no differences compared with control at 12 months. Secondary anthropometric, biomechanical and mental health outcomes were unaltered in either intervention study arm compared with control at 12 or 48 months, with the exception of small, but sustained, reductions in body weight in the Walking Away study arm (≈ 1 kg) at the 12- and 48-month follow-ups. Lifetime cost-effectiveness modelling suggested that usual care had the highest probability of being cost-effective at a threshold of £20,000 per quality-adjusted life-year. Of 50 serious adverse events, only one (myocardial infarction) was deemed possibly related to the intervention and led to the withdrawal of the participant from the study.
Loss to follow-up, although the results were unaltered when missing data were replaced using multiple imputation.
Combining a physical activity intervention with text messaging and telephone support resulted in modest, but clinically meaningful, changes in physical activity at 12 months, but the changes were not sustained at 48 months.
Future research is needed to investigate which intervention types, components and features can help to maintain physical activity behaviour change over the longer term.
Current Controlled Trials ISRCTN83465245.
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in ; Vol. 25, No. 77. See the NIHR Journals Library website for further project information.
2 型糖尿病是全球主要的死亡原因之一,也是重大的医疗资源支出原因。增加身体活动可以降低糖尿病的风险。然而,对于高风险 2 型糖尿病患者,身体活动干预的长期临床效果和成本效益尚不清楚。
研究 Walking Away from Diabetes(Walking Away)——一种低资源、3 小时的基于小组的行为干预措施,旨在通过使用计步器来促进身体活动,是否会在与集成移动健康干预相结合的情况下,导致体力活动持续增加,与对照组相比。
三臂、平行组、实用、优势随机对照试验,在 12 个月和 48 个月时进行随访。
初级保健和社区。
过去 5 年内,他们的初级保健记录中包括糖尿病前期的血糖测量值[糖化血红蛋白(HbA)≥42mmol/mol(6.0%),<48mmol/mol(6.5%)mmol/mol;空腹血糖≥5.5mmol/L,<7.0mmol/L;或 2 小时后葡萄糖负荷≥7.8mmol/L,<11.1mmol/L]的成年人,于 2013 年 12 月至 2015 年 2 月期间招募。数据收集于 2019 年 7 月完成。
参与者使用基于网络的工具进行随机分组(1:1:1),随机分配到(1)对照组(信息传单)、(2)每年进行小组支持的 Walking Away 或(3)Walking Away Plus(包括 Walking Away、每年进行小组支持和移动健康干预,移动健康干预会自动向参与者发送个性化短信,以提示计步器的使用和目标设定,并提供反馈,同时每两个月进行一次电话访问)。参与者和数据收集人员未设盲;但是,处理加速度计数据的工作人员设盲。
主要结局指标是 48 个月时的加速度计测量的日常活动(每天的步数)。还评估了其他客观和自我报告的身体活动测量指标。
共有 1366 人随机分组(中位年龄 61 岁,中位体重指数 28.4kg/m,中位日常活动 6638 步/天,女性占 49%,黑人及少数族裔占 28%)。12 个月和 48 个月时,分别有 1017(74%)和 993(73%)人提供了加速度计数据。在 48 个月的主要结局评估中,与对照组相比,在任何一组中,日常活动都没有差异(Walking Away Plus:每天增加 121 步,97.5%置信区间为-290 到 532 步/天;Walking Away:每天增加 91 步,97.5%置信区间为-282 到 463 步/天)。这在不同种族群体中都是一致的。在 12 个月的中期评估中,Walking Away Plus 组的日常活动增加了 547 步/天(97.5%置信区间为 211 到 882 步/天),与对照组相比,他们更有可能每周进行 150 分钟的非捆绑中度至剧烈体力活动,客观评估。在 Walking Away 组中,与对照组相比,12 个月时没有差异。在 12 个月和 48 个月时,与对照组相比,在任何干预研究组中,次要的人体测量、生物力学和心理健康结果均未改变,除了 Walking Away 组的体重在 12 个月和 48 个月时持续轻微下降(≈1kg)。终生成本效益建模表明,在 £20000 每质量调整生命年的阈值下,常规护理具有最高的成本效益概率。50 例严重不良事件中,只有 1 例(心肌梗死)被认为可能与干预措施有关,导致参与者退出研究。
失访率虽然缺失数据使用多重插补进行替换,但结果未改变。
将体力活动干预与短信和电话支持相结合,在 12 个月时可适度但具有临床意义地改变体力活动,但在 48 个月时没有持续。
需要进一步研究哪种干预类型、组成部分和特征可以帮助在长期内保持体力活动行为的改变。
当前对照试验 ISRCTN83465245。
本项目由英国国家卫生研究所(NIHR)健康技术评估计划资助,将在;第 25 卷,第 77 期。有关该项目的更多信息,请访问 NIHR 期刊库网站。